AirWare Labs and Breathe Active, LLC Announce Retail Agreement With Walmart

AirWare Labs and Breathe Active, LLC Announce Retail Agreement With Walmart 
Nation's Largest Retailer Orders 20,000 Units of Breathe Active's
Licensed Nasal Inserts for Sale in 4,200 Walmart Locations 
SCOTTSDALE, AZ -- (Marketwired) -- 05/22/14 --  AirWare Labs Corp.
(OTCQB: AIRW) and Breathe Active, LLC today announced Walmart will
carry Breathe Active Sleep/Snore products in all of its 4,200 U.S.
stores. Walmart has placed an initial order of 20,000 units to stock
its stores' "As Seen On TV" shelves beginning in June.  
Powered by AirWare's patented nasal insert technology, the Breathe
Active Sleep/Snore increases airflow for better breathing and has
been clinically proven to reduce snoring. 
"This partnership with Walmart is a game changer," said Kevin
Shaughnessy, President and CEO of Breathe Active, LLC. "Not only does
it validate the product, but having the product available at all of
Walmart's US stores allows Breathe Active's growing customer base to
conveniently purchase the product for immediate use. Offering our
products through the nation's largest retailer allows us to reach a
broad audience of consumers seeking to improve their health with
better breathing." 
"We are thrilled that Walmart shoppers will have the opportunity to
access AirWare's proven nasal insert technology," said Jeffrey
Rassas, CEO of AirWare Labs. "Breathe Active's demonstrated success
in the Direct Response TV and "As seen on TV" marketplace is
testimony to the need for effective relief from sleep disorders." 
AirWare Labs and Breathe Active, LLC recently announced expansion of
their licensing agreement into Australia and New Zealand. AirWare
Labs also announced production of a branded video featuring TV and
movie personalities Vincent Kartheiser (of AMC's drama Mad Men) and
Adam Herschman, and disclosed plans for a sales and manufacturing
expansion into China earlier this year. AIR(R) ALLERGY was selected
as a 2014 Visionary Award Finalist for the VISION(R) Consumer
Products Conference in Dallas, and in 2013 AirWare Labs announced a
national rollout into 7,500 Walgreen's stores. 
About AirWare Labs Corporation: 
AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides
patented and innovative technology solutions for consumer products
that promote better health through breathing and enhanced wellbeing.
AirWare Labs' products are marketed under the brand name of AIR(R).
AIR(R) products utilize an FDA approved medical grade material,
molded as an intranasal Air Breathe dilator, to act as the delivery
system. This AIR(R) microstructure enhances normal nasal airflow with
every breath -- clinically proven to deliver up to 40% more oxygen.  
Some AIR(R) products are infused with essential oils with unique
healing properties including antibacterial and therapeutic defense
against airborne allergens, viruses and bacteria. AIR(R) Allergy and
Travel products provide additional defense in the form of an
integrated filter media from 3M to remove microscopic particles that
carry viruses, allergens and bacteria. Other AIR(R) specialty
products help provide and performance enhancements and relief from
congestion, insomnia, headaches, nausea, and snoring. For more
product information, please visit: or
company information visit: 
Forward-Looking Statement: The statements in this press release
regarding any implied or perceived benefits from the release by
AirWare Labs Corp. of its AIR(R) products are forward-looking
statements. Such statements involve risks and uncertainties,
including, but not limited to, risks and effects of legal and
administrative proceedings and governmental regulation, especially in
a foreign country, future financial and operational results,
competition, general economic conditions, and the ability to manage
and continue growth.  
Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual outcomes may
vary materially from those indicated. Important factors that could
cause actual results to differ materially from the forward-looking
statements we make in this news release include the introduction of
new technology, market conditions and those set forth in reports or
documents we file from time to time with the SEC. We undertake no
obligation to revise or update such statements to reflect current
events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events. 
Media Contact: 
Jennifer Breitegan 
Investor Relations:
Keith Pinder
Acorn Management
Press spacebar to pause and continue. Press esc to stop.